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Chapter I. General overview 
1.1 Background and Purpose 
Induced pluripotent stem cells (iPSCs) are applicable tools for modeling of diseases, 
drug development and transplantation medicine. However, several issues regarding to its 
generation will limit the potential in medicine, such as a low number of high quality iPSCs. 
Previous studies have shown that the epigenetic state of X chromosomes in female iPSCs is 
closely linked to pluripotency, an indicator for high quality of iPSCs. Female mouse iPSCs 
with two active X chromosomes (XaXa) exhibit higher pluripotency than iPSCs with one 
active and one inactive X chromosome (XaXi). In order to visualize the X chromosome status 
in live cells and analyze the mechanism of X chromosome reactivation (XCR), I established a 
novel live cell imaging system of XCR.  
1.2 Materials and Methods 
I used the CRISPR/Cas9 system to generate mouse embryonic stem cell (mESC) lines 
that carry two different fluorescent protein genes (EGFP and humanized Kusabira Orange 
(hKO)) on both X chromosomes. Female mESCs were transfected with two different donor 
template plasmids, each of which contains one of the fluorescent protein genes and a drug-
resistant gene between the homologous sequences in the targeted site, together with the 
expression vector of Cas9 and a guide RNA. After selection of drug-resistant mESC clones 
that expressed two fluorescence proteins (EGFP+/hKO+), PCR analysis of their genome DNA 
was performed to confirm that these mESC clones have the expected inserts at the targeted 
sites of both X chromosomes. In order to visualize X chromosome status in live cells, 
candidate mESC clones were differentiated through embryoid bodies (EBs) formation and 
their derived differentiated single-color cells were reprogrammed to generate iPSCs to 
monitor X chromosome inactivation (XCI) and X chromosome reactivation (XCR), 
respectively.  
1.3 Results 
In this study, I observed that the female EGFP+/hKO+ ESC clones express only one of 
the two fluorescent proteins (EGFP+ or hKO+) upon differentiation, indicating that the 
inserted fluorescent protein genes are subject to XCI. Furthermore, when the single-color 
somatic cells were reprogrammed into iPSCs, the iPS colonies displayed double colors 
(EGFP+/hKO+) (“double” signal). These results indicate that my system can also detect XCR 
during reprogramming in a predicted manner. Interestingly, I found out a correlation between 
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the extent of XCR and the level of pluripotency of iPSCs. Colonies with complete XCR 
expressed higher levels of pluripotency marker genes than those with partial XCR. It 
indicates that my system provides a simple method for distinguishing high and low quality 
iPSCs. 
1.4 Conclusions 
- I established a novel detection system of XCR, which can be utilized for visualizing the 
X chromosome status in live cells:  
▪ Tracking X chromosome inactivation (XCI) upon differentiation. 
▪ Monitor X chromosome reactivation (XCR) during reprogramming. 
- My detection system of XCR during reprogramming provides a simple method for 
isolating high quality iPSCs, which are promising materials for regenerative therapy 
research. 
1.5 Abbreviations 
2-ME 2-Mercaptoethanol 
c-Myc Myelocytomatosis oncogene 
Cdh1 Cadherin-1 
CRISPR/Cas9 Clustered Regularly Interspaced Short 
Palindromic Repeats/CRISPR 
associated protein 9 
DD Destabilizing Domain 
DMEM Dulbecco’s modified Eagle medium 
DNA Deoxynucleic Acid 
EpiSC Epiblast Stem Cell 
ESC Embryonic Stem Cell 
EGFP Enhanced Green Fluorescent Protein 
Esrrb Estrogen Related Receptor Beta 
FBS Fetal Bovine Serum 
GSK3βi Glycogen Synthase Kinase 3β Inhibitor 
hKO Humanized Kusabira Orange 
H3K27me3 H3K27 trimethylation 
iPSC Induced Pluripotent Stem Cell 
IRES Internal Ribosome Entry Site 
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Klf4 Krupple-like factor 4 
KSR Knockout Serum Replacement 
LIF Leukemia Inhibitory Factor 
MEF Mouse Embryonic Fibroblast 
MEKi MAPK/ERK Kinase inhibitor 
NEAA Non-Essential Amino Acid 
Oct4 Octamer-binding Transcription factor 4 
PBS Phosphate Buffered Saline 
PCR Polymerase Chain Reaction 
PuroR Puromycin Resistance 
Rex1 Reduced Expression Protein 1 
RNA Ribonucleic acid 
SeVdp Sendai Virus defective and persistent 
Sox2 SRY (Sex determining region Y)-box 2 
Xa Active X chromosome 
Xi Inactive X chromosome 
XCI X Chromosome Inactivation 
XCR X Chromosome Reactivation 
Xist X-inactive specific Transcript   
ZeoR Zeocin Resistance 
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Chapter II. X Chromosome reactivation during reprogramming  
2.1  Introduction 
2.1.1 Induced pluripotent stem cells (iPS cells) 
Embryonic stem cells (ESCs) are stem cells that are derived from the inner cell mass 
of a blastocyst. ESCs are able to divide and renew themselves indefinitely (self-renewal) and 
to differentiate into all types of cell in the embryo proper (pluripotency) [1, 2]. With their 
abilities of self-renewal and pluripotency, ESCs might be used to treat various diseases, such 
as diabetes, spinal cord injury and Parkinson’s disease [3]. ESCs could be also used to 
understand the mechanisms of and screen drugs for various diseases. However, due to ethical 
controversies, it is almost impossible to use human embryos for these purposes. Moreover, it 
is difficult to derive patients’ own ESCs, which are immune-compatible for transplantation. 
These barriers can be overcome by iPSCs, which are induced by from somatic cells by 
somatic cell reprogramming.  
Somatic cells reprogramming occurs when somatic cells are fused with ESCs or when 
their nuclear contents are transferred into somatic cells [4-6], indicating that ESCs contain 
factors that can confer pluripotency to somatic cells. Therefore, these factors are 
hypothesized to play important functions in maintenance and induction of pluripotency in 
somatic cells. These factors include Oct3/4 [7, 8], Sox2 [9], Nanog [10, 11], Klf4 [12] and c-
Myc [13], and they have been show to function in both early embryos and ESCs and 
contribute to the long-term maintenance and rapid proliferation of ESCs in culture. By 
combining these factors, it is possible to generate pluripotent stem cells directly from somatic 
cells such as mouse embryonic or adult fibroblasts. 
iPSCs are a type of pluripotent stem cells that can be generated from somatic cells by 
induction of four specific genes encoding transcription factors – Klf4, Oct4, Sox2 and c-Myc 
[14]. iPSCs are similar to ESCs with regards to cell morphology, high expression of 
pluripotency marker genes, and ability to form embryoid bodies, teratoma and chimeric mice 
[15, 16]. Moreover, tissue-specific cells generated from iPSCs escape from immunological 
rejection upon transplantation since they are derived from a patients’ own cells. In addition, 
since iPSC generation does not require destruction of human embryos, iPSCs pose little 
ethical concerns. Thus, iPSCs can be ideal sources for cell-based therapies to cure diseases 
for which there is currently no effective treatment. 
However, to generate high-quality and safe iPSCs reproducibly, several obstacles 
need to be overcome. The initial iPSC generation system utilized retroviral vectors. 
Retroviral vectors integrate transgenes into the host genome, leading to alterations in the 
5 
 
genome sequence. In particular, the c-Myc gene, which is a proto-oncogene, increases the 
risk of tumor formation after retrovirus-mediated integration into the genomes [17]. 
Moreover, it is still unclear whether iPSCs are genetically and epigenetically equivalent to 
ESCs. A recent study showed that reprogramming is accompanied by copy number variations 
at a high frequency, giving rise to genetic mosaicism of iPSCs [18]. Whole genome profiles 
of DNA methylation in five human iPSC lines as well as ESCs, somatic cells and 
differentiated iPSCs indicate that iPSCs may have the variability in somatic memory and 
DNA methylation, raising the possibility of an unfaithful epigenetic reprogramming [19]. To 
avoid this problem, various methods for integration-free human iPSC generation have been 
reported. One of them is Sendai virus vectors encoding reprogramming factors used to induce 
human fibroblasts and obtained iPSCs [20]. Sendai viruses express reprogramming factors 
stably and generate integration-free iPSCs since they are RNA viruses, which replicate their 
genome in cytoplasm of infected cells.  
Two other major problems in iPSC generation for research or therapy are the 
inefficiency of reprogramming fibroblasts into iPSCs (less than 10% of initial somatic cells 
can be successfully transformed into iPSCs) and the low number of high quality iPSCs in a 
population of reprogrammed cells (less than 0.02%) [21, 22]. In order to overcome these 
problems, the molecular mechanisms that underlie behind somatic cell reprogramming need 
to be clarified. 
2.1.2 X chromosome inactivation and X chromosome reactivation 
2.1.2.1 Dosage compensation 
In mammals, there is a major difference in the composition of chromosomes between 
the two different sexes. Besides pairs of autosomes present in both males and females, there 
are sex chromosomes, X and Y, which differ between male and female. Male has an X 
chromosome and a Y chromosome whereas female has two X chromosomes. The 
chromosomal difference is critical for determining the sex of individual mammals.  
The X chromosome is large and gene rich, possessing more than 1,000 annotated 
genes while the Y chromosome is small and gene poor. The two sexes also differ in the copy 
number of X-linked genes, which leads to imbalance in the amount of gene products between 
male and female. Imbalanced expression of several X-linked genes presumed to be lethal. 
Therefore, it needs to be dealt with by a mechanism to compensate for gene dosage (dosage 
compensation), by which expression of X-lined genes between different sexes is equalized. 
The dosage compensation is achieved by three main mechanisms. Firstly, X-linked gene 
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expression from a single male X chromosome is up-regulated by two fold [23]. Secondly, X-
linked gene expression from female X chromosomes is down-regulated by two fold [24]. 
Finally, one of two X chromosomes is completely inactivated in female.  
Two-fold up-regulation of X-linked genes in male was first reported by Muller in 
1932 [25]. He tracked differences in Drosophila melanogaster’s eye color, which is under 
control of an X-linked gene, among male and female mutants. Muller mutated a gene that led 
to the loss or reduction of pigment in the eyes of a fly. Compared with females with two 
copies of the mutant gene, males with one copy of the mutant gene showed a similar degree 
of pigmentation, which he termed as “dosage compensation”. In 1965, more advanced 
autoradiography experiments were performed to further confirm Muller’s observed 
phenomenon of dosage compensation. Mukherjee and Beermann designed an experiment to 
visualize [3H]-Uridine incorporation into RNAs expressed from X chromosomes. Levels of 
[3H]-Uridine incorporation in the single male X chromosome was equal to the two female X 
chromosomes [26]. These results confirmed Muller’s hypothesized dosage compensation. 
Recent technologies, microarrays and high throughput RNA sequencing have also provided 
strong evidence for this hypothesis in mammals [27-29]. 
However, in Caenorhabditis elegans, the system of sex determination is different [30]. 
C. elegans with two X chromosomes (XX) are hermaphrodites, and those with one X 
chromosome (XO) are males [31]. Similar to the XX/XY sex determination system, the 
difference in the number of X chromosome between sexes leads to differences in the 
expression levels of X-linked genes. In hermaphrodites, the normal expression of genes from 
both X chromosomes is lethal. To compensate dosage, hermaphrodites broadly reduce the 
expression levels of genes on both X chromosome. In the XX hermaphrodites, this repression 
occurs by two-fold down-regulation of transcription from both X chromosomes. This down-
regulation is achieved by a specific complex on the X chromosomes in XX hermaphrodites, 
termed dosage compensation complex (DCC). Components of this complex are homologous 
to the condensin protein complex, which plays a central role in chromosome condensation 
and segregation during mitosis and meiosis. This homologue has led to the hypothesis that 
the DCC achieves X-linked gene repression by partially condensing the X chromosomes.  
In 1949, Barr and Bertram observed a structure in the nuclei under a light microscope. 
They observed various mammalian species to find that this structure was present in nuclei of 
only female cells and therefore named it sex chromatin body. Thereafter, in 1959, Ohno 
showed that this structure was from one of the two female X chromosomes. He called these 
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structures Barr bodies. Ohno’s studies of Barr bodies in female mammals revealed that these 
females used Barr bodies to inactivate one of their X chromosomes. Later, in 1961, Mary 
Lyon performed experiments on the expression of coat color genes on the X chromosome in 
female mice. Lyon proved that every cell of the female body inactivated either maternal or 
paternal X chromosome in a random mode. This result confirmed the heterogeneous patterns 
she observed in her mosaic mice. This process is known as random X chromosome 
inactivation [32]. Shortly thereafter, skin fibroblasts from a female who is heterozygous at the 
glucose-6-phosphate dehydrogenase G6PD) locus were grown in culture to isolate fibroblast 
clones. Only one allele was expressed in each clone originating from a single fibrablast, 
demonstrating the inactive state is inherited from one cell generation to the next, and random 
X chromosome inactivation occurred in human females [33, 34]. Thus, in mammals, dosage 
compensation is achieved by silencing one of two female X chromosomes via X chromosome 
inactivation.  
2.1.2.2 X chromosome inactivation (XCI) 
As compared with males, female mammals have a special epigenetic gene regulatory 
mechanism termed X chromosome inactivation (XCI) to deal with the gene dosage imbalance 
between females (XX) and males (XY). It is a compensation mechanism that occurs early in 
female embryonic development. Transcriptional silencing of one X chromosome is 
accomplished in diploid cells in epiblasts, and once established, the inactivated X 
chromosome is stably inherited through subsequent cell divisions. In the embryo, XCI occurs 
at random and leads to a mosaic distribution of cells which express either the maternal or 
paternal X chromosome [32].  
Although random XCI occurs in all mammals, researchers have largely focused on the 
mouse system to investigate the underlying mechanisms of XCI. The inactivated X 
chromosomes (Xi) is condensed into a structure termed Barr body, and firmly maintained in a 
silent state upon subsequent cell divisions [35]. X inactivation center (Xic), a region on the X 
chromosome, controls initiation of XCI. This process depends on the upregulation of X 
inactive speciﬁc transcript (Xist) on one of the X chromosomes. Xist produces a long 
noncoding RNA (ncRNA) that accumulates and coats over the Xi chromosome in cis and 
triggers its transcriptional silencing [36, 37]. Thereafter, it mediates chromatin modiﬁcations, 
such as loss of RNA polymerase II and nascent transcripts, gain of chromatin marks 
associated with Polycomb group (PcG) complex, loss of histone H3 lysin 4 trimethylation 
(H3K4me3) and acetylation of histone H3 (H3ac) [38]. A mono-ubiquitination of histone 
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H2A lysine 119 (ubH2A) is mediated by polycomb repressive complex 1 (PRC1) and 
trimethylation of histone H3 lysine 27 (H3K27me3) is catalyzed by PRC2 on the Xi 
regulation [39-44]. 
Tsix, a non-coding RNA that is antisense to the Xist RNA, is known to partly mediate 
regulation of Xist transcription [45]. In undifferentiated ESCs, Xist expression is strongly 
repressed to ensure the active status of X chromosomes [46]. Tsix is involved in maintaining 
low levels of the Xist RNA in these cells. Targeted deletion of the Tsix gene has revealed that 
the Tsix RNA represses transcription of the Xist gene in cis. Any alteration in the Tsix gene 
that results in a lowered level of the Tsix  RNA leads to skewed XCI with silencing of the X 
chromosome [47]. 
A previous study has shown that the Tsix gene may not be directly involved in 
regulation of Xist expression [46]. Bothe Xist and Tsix genes are targets of pluripotency 
factors. In undifferentiated mESC, Nanog, Oct4 and Sox2 have been reported to bind the ﬁrst 
intron of the Xist gene [48]. Male ES cells being knocked-out of Oct4 and Nanog showed 
upregulation of the Xist gene, and this upregulation was independent of repression by the 
Tsix RNA. These results indicate that Oct4 and Nanog repress Xist transcription in mESCs 
independently of the Tsix. 
 
Reference Figure 1. Model for molecular link between Xist repression and pluripotency 
factors [49] 
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While targeted deletions of pluripotency factors revealed the importance of their Xist 
intron 1 binding site [50], it also results in down-regulation of Xist activators such as Ring 
ﬁnger protein 12 (Rnf12) [51]. Consistently, Oct4, Sox2 and Nanog bind to the 5’ region of 
the Rnf12 gene [52, 53]. In ESCs, Oct4 and Sox2 have also involved in Tsix upregulation by 
binding the Tsix enhancer regions [54]. In addition, Tsix expression in ESCs depends on 
Rex1 in addition to c-Myc and Klf4, all of which bind 5’ regulatory regions of the Tsix gene 
as well. In fact, Rex1 is found to be important for transcriptional elongation of the Tsix gene 
[55]. Besides, when ES cells are differentiated, Rex1 expression is lost rapidly, suggesting 
that activation of the Tsix gene is reduced through loss of Rex1, and this reduction 
contributes to the initiation of XCI.  
2.1.2.2 X chromosome reactivation (XCR) 
X chromosome status changes dynamically during early mouse development [38] [56]. 
Paternal X chromosome (Xp) is inactivated at the 4-cell stage, which is commonly known as 
imprinted XCI. Imprinted Xp chromosome is activated in the inner cell mass (ICM) of 
blastocysts, resulting in two active X chromosomes (XaXa). This phenomenon is termed X 
chromosome reactivation (XCR). In epiblasts, either the paternal (Xp) or maternal (Xm) X 
chromosome is silenced by random XCI.  
Germ cells are the only cells that escape stable somatic inheritance of X chromosome 
inactivation. Therefore, the mechanisms of Xi reactivation has been focused on primordial 
germ cells (PGCs) and investigated by several studies. It is reported that the process of XCR 
can be divided into three main steps, (1) Xist expression is repressed, (2) histone mark 
H3K27me3 dissipates from the Xi, and (3) X-linked genes are reactivated from the Xi. 
Reactivation of genes on the Xi occurs gradually and this process also overlaps with changes 
in chromatin modiﬁcations and DNA demethylation [57]. Interestingly, the timing of Nanog 
expression and the initiation of Xist repression appears in E7.5 PGCs [58], consistent with 
Nanog expression in ICM which is essential for the establishment of pluripotency [59]. 
Expression of the Xist RNA from imprinted paternal Xi is also repressed in Nanog+ cells of 
the ICM [60]. Furthermore, in 2008, Silva and colleagues have reported that Xist repression 
and Xi reactivation at the transition from pre-iPS cells to iPS cells correlates with Nanog 
expression [61].  
It has been proven that in ESCs, recruitment of Polycomb group (PcG) depends on the 
Xist RNA, therefore, loss of Xist expression could be an explanation for loss of H3K27me3 
from the Xi [42] [62]. Nonetheless, it remains unclear whether repression of the Xist gene is 
10 
 
necessary for Xi reactivation in PGCs. During PGC development, several prominent events 
occurs such as changes in epigenetic modiﬁcations, including histone modifications and DNA 
demethylation. These events are thought to regulate reprogramming of the germline cells [57]. 
This makes PGCs an interesting system to investigate the mechanism and epigenetic 
processes of Xi reactivation. 
By reprogramming female somatic cells into iPSCs, XCR can also be achieved [63]. 
XCR is a late event during reprogramming process to generate induced pluripotent stem cells 
(iPSCs) [64] [65]. Of note, XCI has attracted much attention in basic research in 
developmental biology, stem cell research and regenerative biology. However, its reverse 
process, XCR, remains one of questions that require further investigations. 
2.1.2.3 X chromosome activities and human diseases 
Human diseases could be strongly influenced by the establishment of X inactivation 
during development, indicating that any abnormal process of XCI can influence phenotype 
severity of recessive X-linked mutations [66, 67]. Tumorigenic process is also linked to XCI 
since an unisomy of X chromosomes which can profit recessive X-linked mutation during 
tumorigenesis [68]. Moreover, loss of Xi or amplification of Xa have been observed in 
ovarian and breast cancers [69].  
To date, mouse model has been widely used to study XCI, therefore, XCI mechanism 
in other mammalian species is less well known. Ethical and technical issues related to human 
embryos and its derived ESCs have been hindrances to investigation of XCI mechanism in 
human development. The difficulty to obtain biological materials from early development has 
limited the study of XCI in humans. 
Scientists have been currently focusing in Xi reactivation in order to deﬁne the 
reprogrammed pluripotent cell state and understand chromatin changes during 
reprogramming. Xi reactivation has also been considered for investigating human genetic 
diseases in female patients, which are caused by mutations on one of the two X chromosomes. 
Therefore, studies on Xi reactivation become a prominent topic for basic research as well as 
potential clinical applications in the future. 
2.1.3 XCR – The key to unlock roadblock for high quality iPSCs 
During early development stages from pre-implantation to post-implantation, 
pluripotent stem cells can be established from ICM and post-implantation epiblast cells. The 
embryonic stem cells (ESCs) are established from pre-implantation ICM and is termed naïve 
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pluripotent stem cells (PSCs). Epiblast stem cells (EpiSCs) are established from post-
implantation stage epiblasts and termed primed PSCs. Primed EpiSCs represent a more 
differentiated state than naïve ESCs [65]. These two types of pluripotent stem cells differ in 
their optimal culture conditions, which reflect different signaling pathways involved in 
maintaining self-renewal and pluripotency. The maintenance of mESCs depends on LIF and 
BMP4, or inhibition of the MAP and GSK3 kinase pathways [70, 71], whereas the 
maintenance of EpiSCs requires both Activin and FGF2 [72, 73]. 
Naïve ESCs exhibit unlimited self-renewal capacity. When injected to the 
preimplantation embryos, they are readily incorporated into the epiblasts and enter embryonic 
development to produce mouse chimeras [74]. The EpiSCs also express some core 
pluripotency factors such as Oct4 and Sox2. However, they still differ from ESCs in 
expression patterns of several other transcription factors. EpiSCs show a “primed” pluripotent 
state and have capability in differentiating into various cell types in vitro, such as teratoma 
formation. Nevertheless, they fail to contribute to blastocyst chimeras, which indicates the 
ability of differentiation in EpiSCs is lower than naïve ESCs [75, 76]. Interestingly, X 
chromosome status is a most important difference between ESCs and EpiSCs. In female cells, 
naïve ESCs have two active X chromosomes (XaXa), while primed EpiSCs have one active 
and one inactive X chromosome (XaXi). These epigenetic differences could be considered as 
markers to distinguish two different states of PSCs. In addition, introduction of Klf4 allows 
EpiSCs to reprogram to naïve pluripotency state together with reactivation of the X 
chromosome [75]. Therefore, XCR could be a marker for good quality of female PSCs. 
 Furthermore, it is suggested that by experimentally inducing a chromatin environment 
related to mouse ESCs, a faster and more efficient reprogramming could be done [77]. It has 
been reported that the efficiency of mouse cloning is increased by deletion of the Xist gene 
[78], suggesting that XCR may pose a roadblock to efficient reprogramming. Previous studies 
have also shown that the epigenetic state of X chromosome in female iPSCs is tightly linked 
to pluripotency. Female mouse iPSCs with two active X chromosome (XaXa) exhibit higher 
pluripotency than iPSCs that have only one active X chromosome (XaXi). Thus, XCI and 
XCR are tightly linked to the loss and gain of pluripotency [79].  
The generation of iPSCs has opened huge promising applications in regenerative 
medicine. It also provides a unique tool to study genetic diseases in vitro. Moreover, in order 
to establish animal models for human diseases which link to X chromosome, high-quality 
female iPSCs are preferable. As mentioned above, the presence of two active X 
chromosomes is considered as an indicator for the quality of iPSCs. Thus, deep 
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understanding on the XCR mechanism will enable us to overcome the roadblock of iPSC 
generation. 
2.1.4 Model to detect X chromosome status in live cells 
XCI has been focused for more than 50 years and to support XCI researches, various 
methods or techniques have been developed for its analysis. Common XCI detection methods 
are summarized in Reference Table 1. X-linked green fluorescent protein (GFP)-expressing 
transgenic mice are widely used to detect XCI in live cells [80-83]. Easy distinction between 
inactive and active X chromosome by observing green fluorescent makes these transgenic 
mice useful for XCI research. The fact that no pre-treatment is required for the samples is an 
advantage of this model. Nonetheless, since they can only be used to monitor the activity of 
one X chromosome, these mice show limitations for some research purposes.  
XCR has been attracting more attentions in recent years. Although XCR is genetically 
considered as a marker to distinguish naïve from primed state PSCs, the common XCR 
detection method is also fixation of cells or tissues to detect the H3K27me3 immunostaining 
pattern. Consequently, it is impossible to further characterize these cells. Common XCR 
detection methods are also summarized in Reference Table 2. Due to the lack of a live 
imaging system to monitor XCI and XCR, there is a major obstacle in stem cell research 
using live PSCs. In order to visualize the X chromosome status in live cells and further 
extensively examine the mechanism of XCR, I established a novel live cell imaging system 
of XCR. The live imaging approach will enable us to monitor the changes in X chromosome 
status in these cells. More precise observations in vitro will enable us to understand the 
mechanisms of XCI and XCR in vivo. 
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Reference Table 1. Summary of XCI detection methods (Summarized from Reference [84]) 
Method Pretreatment 
of samples 
Note Reference 
Observation of Barr body Fixation Xi dark staining  [85] 
Replication timing Fixation Xi shows late replication within the S phase of the cell cycle [86] 
Enzymatic activity Cell extraction Activities of X-linked enzymes (Hprt, Pgk1) [87, 88]  
RNA fluorescent in situ 
hybridization (FISH) 
Fixation Detection of X-linked gene expression [60] [89, 
90] 
Allele-specific expression analysis RNA extraction Allele-specific expression analysis using DNA polymorphism [91, 92]  
Antibodies Fixation Immunostaining of H3K27me3, DNA polymerase II [90] 
Transgenic ESCs Noninvasive Ezh2-Venus transgenic ESCs to detect Xi [93, 94]  
Transgenic mice Fixation HMG-lacZ transgene inserted into X chromosome to detect its activity [95] 
Noninvasive CAG-eGFP transgene inserted into X chromosome to detect its activity [80, 81]  
Noninvasive microH2A-eGFP transgene inserted into autosomes to detect Xi [82] 
Noninvasive 
 
CAG-GFP and CAG-tomato transgenes inserted into X chromosomes to 
detect their activities 
[83] 
Noninvasive CAG-GFP and CAG-mCherry transgenes inserted into X chromosomes to 
detect their activities 
[96] 
Ezh2: enhancer of zeste homologue 2; HMG-lacZ: 3-hydroxy-3-methylglutaryCoA (HMG) promoter driving the Escherichia coli beta-
galactosidase (lacZ) gene; Hprt: hypoxanthine phosphoribosyltransferase; Pgk1: phosphoglycerate kinase 1
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Reference Table 2. Summary of XCR detection methods (Summarized from Reference [97]) 
Method Pretreatment of 
samples 
Note Reference 
Replication timing Fixation Reactivation of X-linked gene (Pgk1) [98] 
RNA fluorescent in situ 
hybridization (FISH) 
Fixation Tsix expression, Xist repression, loss of H3K27me3, X-linked gene 
reactivation (Pgk1) 
[61] [63] 
DNA methylation Cell extraction Methylation status on Xist promoter [99] 
Microarray analysis RNA extraction Xist repression and increasing X-linked genes [100] 
Transgenic cells RNA extraction CMV-GFP transgene inserted into X chromosome to detect its 
activity. Tsix expression, Xist repression, X-linked gene reactivation 
(X-linked-GFP transgene) 
[101, 102]  
Transgenic mice Noninvasive CAG-GFP and CAG-mCherry transgenes inserted into X 
chromosomes to detect their activities 
[96] 
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2.2 Materials and Methods 
2.2.1 Plasmids and guide RNAs 
The pX330-U6-Chimeric_BB-Cbh-hSpCas9 (#42230) and pCAG-EGxxFP (#50716) 
were purchased from Addgene. pPyCAG-EGFP-IP and pPyCAG-EGFP-IZ were generous 
gifts from Dr. Hitoshi Niwa (RIKEN CDB). Guide RNAs (gRNAs) were designed using 
CRISPRdirect (https://crispr.dbcls.jp), and the gRNAs that had the minimum potential off-
target effects were chosen for the S and T site as shown in Table 1. The B6N mouse Bac 
clones B6Ng01-177J10 (for the S site) and B6Ng01-316J16 (for the T site) were provided by 
the RIKEN BRC through the National Bio-Resource Project of the MEXT, Japan. 
2.2.2 Construction of plasmids 
To construct pCAG-EGxxFP-based validation plasmids, 600 bp~1700 bp genomic-
DNA fragment containing the gRNA target sequences for S or T site was amplified from the 
mouse Bac clone and inserted into the multiple cloning site of the vector (Table 2). 
Complementary pairs of oligonucleotides encoding the gRNAs were annealed and inserted 
into the BbsI site of pX330-U6-Chimeric_BB-Cbh-hSpCas9 to prepare the Cas9/gRNA-
expression vectors. The targeting vectors for knock-in of the fluorescent protein-coding genes 
into the S or T site were constructed using pPyCAG-EGFP-IP and pPyCAG-EGFP-IZ. The 
CAG promoter was replaced by the human elongation factor alpha-1 (EF-1) promoter, and 
the EGFP gene in pPyCAG-EGFP-IZ was replaced by hKO gene. The DNA fragment around 
the target site of gRNA1 (S site) or gRNA5 (T site) were isolated from the B6N mouse Bac 
clones and inserted into the upstream of the fluorescent protein-coding gene and downstream 
of the drug-resistant gene. 
2.2.3 Transfection of HEK293 cells 
Human embryonic kidney (HEK293) cells (RIKEN BRC, RBRC-RCB1637) were 
seeded at 1.5 x 105 cells/well in a 24-well plate and cultured at 37°C under 5% CO2 for 12 
hours in Dulbecco’s modified Eagle’s medium (DMEM) (Nacalai tesque, Inc.) supplemented 
with 10% fetal bovine serum (FBS) (Thermo Fisher Scientific Inc.). Five hundred nanogram 
each of pX330-Cas9/gRNA-expression vector and pCAG-EGxxFP containing the gRNA 
target sequence were mixed with 2 µl of Lipofectamine® 2000 (Thermo Fisher Scientific 
Inc.), and the mixture was added to the HEK293 cells according to the manufacturer’s 
protocol. EGFP expression was observed under a fluorescent microscope on the second day 
after transfection. 
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2.2.4 Transfection of mouse ES cells 
Female mESCs (RIKEN BRC, AES0010) were seeded at 5x105 cells/well on SNL 
feeder cells harboring the puromycin-resistant gene in a 6-well plate and cultured at 37°C 
under 5% CO2 for 5 hours in DMEM supplemented with 1 mM sodium pyruvate (Nacalai 
tesque, Inc.), 15% KnockOut Serum Replacement (KSR) (Thermo Fisher Scientific Inc.), 0.1 
mM nonessential amino acids (NEAA) (Wako pure chemical industries, Ltd.), 0.1 mM 2-
mercaptoethanol (2-ME) (Thermo Fisher Scientific Inc.) and 1,000 U/ml LIF (Oriental Yeast 
Co., LTD.). Two microgram each of pX330-Cas9/gRNA expression vector and two different 
targeting vectors (phEF1-EGFP-IP-Syap1 and phEF1-hKO-IZ-Syap1, or phEF1-EGFP-IP-
Taf1 and phEF1-hKO-IZ-Taf1) were mixed with 10 µl of Lipofectamine® 2000, and the 
mixture was added to the mESCs. The medium was changed to fresh same medium 5 hours 
after transfection to minimize the cell toxicity. Then the cells were treated with 1 µg/ml 
puromycin for 5 days followed by treatment with 50 µg/ml zeocin for 3 days to isolate 
EGFP/hKO-double positive mESC clones.  
2.2.5 Genotyping analysis of isolated ESC clones 
Genomic DNAs were extracted from the isolated EGFP/hKO-positive mESC clones 
and used as templates for PCR. To avoid contamination with feeder cells, the EGFP/hKO-
positive mESCs were cultured without feeder cells for 5 days prior to DNA extraction. The 
location of primer sets used for PCR were shown in Fig. 4 and 5, and their sequences are 
listed in Table 3.  
2.2.6 Differentiation of the EGFP+/hKO+ mESC clones 
The isolated EGFP+/hKO+ mESC clones were grown on SNL feeder cells in a 100mm 
dish until the density becomes 80% confluent and trypsinized to suspend in the DMEM 
supplemented with 20% FBS, 0.1 mM NEAA and 0.1 µM 2-ME. The cell suspension was 
transferred to a 100mm cell culture dish and incubated for 20 minutes to remove feeder cells 
which attach to the dish quickly. Then, the supernatant containing the EGFP/hKO-positive 
mESCs was collected and plated into a 100 mm non-coated bacterial dish (AGC TECHNO 
GLASS CO., LTD.) for formation of embryoid bodies (EBs). After 5 days, EBs were 
trypsinized and filtrated through a 100 µm cell strainer (BD Falcon). The filtrated cells were 
cultured on a collagen Type I-coated dish (AGC TECHNO GLASS CO., LTD. and 
Sumitomo Bakelite Co., Ltd) in the presence of 50 µg/ml zeocin to select hKO-positive 
single-colored cells.  
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2.2.7 Reprogramming of the EGFP+/hKO+ mESC-derived differentiated cells 
The isolated hKO+ differentiated cells were seeded in a 24-well plate at 2.5x104 
cells/well in DMEM plus 10% FBS and cultured at 37°C under 5% CO2 for 12 hours. The 
cells were infected with the Sendai virus which expresses Klf4, Oct4, Sox2 and c-Myc 
(SeVdp(KOSM)) for 16 hours at 32°C to induce reprograming. The virus-infected cells were 
trypsinized and cultured on SNL-feeder cells in Knockout DMEM (Thermo Fisher Scientific 
Inc.) supplemented with 15% KSR, 2 mM GlutaMAX (Thermo Fisher Scientific Inc.), 0.1 
mM NEAA, 55 µM 2-ME, 100 units/ml penicillin, 100 µg /ml streptomycin (Nacalai tesque, 
Inc.) and 1000 U/mL LIF for 7 days. The culture medium was replaced by 2i medium (1:1 
mixture of DMEM/F12 (Nacalai tesque, Inc.) and Neurobasal medium (Thermo Fisher 
Scientific Inc.) supplemented with N2 supplement (Thermo Fisher Scientific Inc.), B27 
supplement (Thermo Fisher Scientific Inc.), 2 mM GlutaMax (Thermo Fisher Scientific Inc.), 
NEAA, 0.1 mM 2-ME, 0.05% BSA (Thermo Fisher Scientific Inc.), 1,000 U/ml LIF, 1 µM 
MEK inhibitor PD0325901, 3 µM GSK3β inhibitor CHIR99021, 100 units/ml penicillin and 
100 µg/ml streptomycin) or DMEM supplemented with 1 mM sodium pyruvate, 15% KSR, 
0.1 mM NEAA, 0.1 mM 2-ME and 1,000 U/ml LIF for continuous culture of iPSCs. 
2.2.8 Reverse transcription and quantitative real-time PCR  
Total RNA was extracted from the EGFP+/hKO+ mESCs, embryoid bodies, 
differentiated cell and EGFP+/hKO+ iPSCs using Sepasol-RNA I Super G (Nacalai tesque, 
Inc.) according to the manufacture’s instruction. To avoid contamination with feeder cells, 
the EGFP+/hKO+ mESCs and hKO+ cells-derived iPSCs were cultured without feeder cells 
for 5 days prior to RNA extraction. Reverse transcription was performed using Superscript III 
First-Strand Synthesis System (Thermo Fisher Scientific Inc.), and the synthesized first-
strand cDNA was used to measure the mRNA level of various marker genes by quantitative 
real-time PCR using GoTaq qPCR Master Mix (Promega Corp.). The mRNA level of γ-
tubulin was used to normalize the obtained data. 
2.2.9 Statistical analysis 
The data were analyzed by t-test analysis to perform the statistical analyses. P values 
of <0.05 were considered significant. The data are presented as the mean ± standard error 
(SE). 
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2.3 Results 
2.3.1 Establishment of detection system of X chromosome status 
2.3.1.1 Novel detection system of X chromosome status in live cells 
In order to visualize the X chromosome status in live cells and analyze the mechanism 
of X chromosome reactivation (XCR), a novel detection system of XCR is established. Two 
reporter genes encoding two different fluorescent proteins, enhanced green fluorescent 
protein (EGFP) and humanized Kusabira orange (hKO), are inserted into each X 
chromosome of female mouse embryonic stem cells (mESCs). These cells are expected to 
initially display both green and orange fluorescence owing to two active X chromosomes. 
Upon differentiation, they show either green or orange fluorescence, indicating that the 
mESC clones undergo X chromosome inactivation (XCI). Single-color cells are 
reprogrammed into iPSCs. High quality iPSCs display two fluorescence, indicating XCR 
upon reprogramming (Fig. 1). 
2.3.1.2 Knock-in fluorescent protein-coding genes into X chromosomes 
To visualize XCR in live cells during somatic cell reprogramming, I first generated 
female ESCs that express EGFP from one X chromosome and hKO from the other. To insert 
the EGFP and hKO genes into the genome, I avoided protein-coding genes as an insertion site 
because of their potential effect as a facilitator or inhibitor on the reprogramming process 
when iPSCs are generated [103]. Instead, I chose two intergenic sites near the Syap1 or Taf1 
gene on the X chromosomes (Fig. 2). These sites were chosen because the insertion sites, 
which I term S and T sites, are near the genes, Syap1 and Taf1, respectively, that are subject 
to XCI [104]. In addition, database search of National Center for Biotechnology Information 
(NCBI) showed that the genes surrounding the S site (Syap1, Txlng, Rbbp7, and Ctps2) and 
the T site (Taf1, Nono, Zmym3, and Med12) do not exhibit strong tissue- or developmental 
stage-specific expression pattern. Moreover, the GeneProf database 
(http://www.geneprof.org/) [105] showed that these sites are sandwiched between CTCF 
binding sites together with at least one of these surrounding genes. Thus, the EGFP and hKO 
genes that are inserted into the S and T sites were expected to obey XCI and XCR in a similar 
manner to the surrounding genes. 
By using the CRISPR/Cas9 system, I insert two reporter gene cassettes encoding two 
different fluorescent proteins into specific sites. I expected that different insertion sites might 
provide different monitoring results as a recent research has suggested that XCI is not 
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uniform throughout chromosomes [106], therefore, XCR might be different. At each site, 
different guide RNAs (gRNA) specific for each site were designed (Fig. 2).  
To validate the working of gRNA sequences for targeting S site, I cotransfected the 
pCAG-EGxxFP target sequence and pX330-hSpCas9-gRNA plasmids into HEK293 cells and 
then the reconstituted EGFP fluorescent was observed 48 hours after transfection. In the 
presence of gRNA sequences, the transfected cells became fluorescent. EGFP expression 
levels were also different between gRNAs. Among three tested gRNAs, gRNA1 showed the 
strongest fluorescent signal while compared with other gRNAs (Fig. 3A). This result 
indicated that gRNA1 has better efficiency on targeting genomic sequence and it is able to be 
used to target desired genomic DNA region. Similarly, on T site, I also tested gRNAs to 
target this site efficiently. As shown in Fig. 3B, gRNA5 was selected for targeting female 
mESCs. 
Following the validation of gRNA in HEK293 cells, I prepared different targeting 
vectors, each of which contained one of the fluorescent protein genes and a drug-resistant 
gene between the homologous sequences in the targeted site (S site: Fig. 4A, 4B) (T site: Fig. 
5A, 5B). To generate mouse embryonic stem cell (mESC) lines that carry two different 
fluorescent protein genes on each allele on both X chromosomes, I transfected targeting 
vectors together with the expression vector of Cas9 and a guide RNA into female mESCs. In 
this study, I tested two different strategies to knock in fluorescent protein-coding genes into 
X chromosomes. The first strategy is step-by-step method by which mESC clones harboring 
the EGFP gene in one allele of X chromosome are isolated and then used to insert the hKO 
gene into the other allele (Fig. 4 and Fig. 5). The second strategy is simultaneous delivery of 
two different fluorescent protein coding genes into cells (Fig. 7 and Fig. 8). 
a. Step-by-step method for knocking in fluorescent coding genes into X 
chromosomes 
The first strategy is step-by-step method by which mESC clones harboring the EGFP 
gene in one allele of X chromosome are isolated and then used to insert the hKO gene into 
the other allele (Fig. 4C). Though CRISPR/Cas9 system has been widely used in genome 
editing, it has not been well-established procedure to generate gene knocked-in ESC lines. 
Therefore, I first determined conditions suitable for establishing ESC lines with minimized 
non-specific integration. For 24 well plate scale, I transfected female mESCs Cas9/gRNA 
expressing plasmid together with different amount of EGFP targeting vectors. Following 
transfection process, the transfected cells were selected by addition of puromycin. After 
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seven days of transfection, the EGFP+ colonies were counted and compared between samples. 
As shown in Fig. 4D and 4E, increasing amount of targeting vector increased EGFP+ colonies. 
Nonetheless, non-specific integrated EGFP+ colonies also increased (samples without gRNA) 
although colony number in 0.5 µg, 1.0 µg, 2.0 µg targeting vector samples were almost 
similar. Therefore, to minimize random integration of EGFP gene, I decided to use 0.5 µg 
targeting vector together with 0.5 µg Cas9/gRNA expressing vector.  
To generate mESC clones harboring the EGFP gene in one allele of X chromosome, I 
transfected optimized combination of Cas9/gRNA expressing plasmid together with EGFP 
targeting vector into female ESCs. Puromycin were added to cultured cells to select 
transfected cells. Green colonies after puromycin selection were collected to validate EGFP 
insertion in one allele of X chromosome (Fig. 4F and 4G). On S site, as a suggestive of 
homologous recombinant (HR) mediated genome editing, colonies were detected to carry the 
expected 9.5 kb fragment. PCR analysis with indicated primer set (shown in Fig 4A) 
confirmed candidate ESC clone with expected insertion (Clone #19). This clone was used to 
insert hKO coding gene into second allele of X chromosome. Zeocin was added after two 
days of transfection. After second transfection, I could observe double-colored (EGFP and 
hKO expression) colonies as indication for hKO insertion (Fig. 4H). PCR analysis with 
primers detecting full length of insertion showed initial heterozygous mESCs became 
homozygous ones (clones marked with red rectangles). However, hKO gene could not be 
inserted into another allele of X chromosome (Fig. 4K). The similar number of double-
colored colonies between samples transfected with and without gRNA (Fig. 4L) indicated 
that hKO gene was randomly integrated into genome. Using this method, I failed to knock-in 
two fluorescent protein coding genes into both alleles of X chromosomes.  
At T site, I also proceeded same procedure to generate EGFP+/hKO+ ESC lines. After 
first transfection, I could generate three clones (#34, #40, #43) with EGFP insertion in one 
allele (Fig. 5F). These three clones were both used to insert hKO gene into second allele of X 
chromosome. However, I could not detect any hKO insertion in double-colored colonies. 
Similar to S site, step-by-step method was not suitable for knocking-in fluorescent protein 
coding genes into specific site. 
b. Effect of medium components on EGFP+/hKO+ mESC generation 
During generation of EGFP+/hKO+ mESCs, taken advantage of double-color ESC 
system, I found out that my current ESC culture medium (DMEM supplemented with KSR 
and LIF) is not suitable to maintain pluripotency of mESCs. Candidate double-colored mESC 
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clones could not survive under drug selection, indicating one of X chromosomes was 
inactivated during culturing. 2i medium (Serum-free medium supplemented with two 
inhibitors – MEK and GSK inhibitors) is proven to be the standard for ES cell culturing. 
However, a drawback with 2i medium is that it generates cultures that are very difficult for 
transfection. Therefore, I tested transfection efficiency with different medium: 2i medium; E 
medium (current medium), E+2i(s) medium, 50/50 medium. Components of each medium 
were listed in Fig. 6A. Experimental procedure was followed as shown in Fig. 6B. Female 
ESCs were cultured in four different media. The cells were transfected Cas9/gRNA plasmid 
together with two targeting vectors. After two days of transfection, puromycin was added to 
cultured medium.  Morphology and fluorescent signal of transfected cells were monitored 
daily during transfection. Double-colored colonies surviving after drug selection were then 
collected, validated both EGFP and hKO insertion at both alleles of X chromsomes. 
Recombination was confirmed by polymerase chain reaction (PCR) analysis of their genome 
DNA (Fig. 6E-G) with different primer sets as shown in red arrows in Fig. 4A and 4B. On S 
site, as a suggestive of homologous recombinant (HR) mediated editing genome, colonies 
were detected to carry the expected 9.5 kb fragment (Primers: a+b). mESC clones having the 
expected EGFP and hKO inserts at both alleles of X chromosomes (Primers: a+c, a+d) were 
marked in red. Targeting efficiency in each medium were also calculated (Fig. 6H). On tested 
S site, cells responsed differently to medium. The number of double-colored colonies after 
transfection were different between medium. 2i medium seems to prevent random integration 
of targeting vector (without gRNA) outside of targeted region. However, this medium is too 
severe for transfected cells, few cells could survive. In E+2i(s), higher number of double-
colored colonies were obtained, it still resulted in high percentage of random integrated 
colonies. 50/50 medium showed highest targeting efficiency among mediums. For the 
observation during transfection, this medium also supported transfected colonies growing 
with round shapes and maintaining fluorescent signals than other medium. Perhaps, it is 
combination of 2i medium and E medium. One is known to maintain stem cells at naïve state, 
and one is a standard serum-containing medium with LIF, which could support cell expansion 
faster than other medium. In my study, it is recommended to culture the cells in this 
combined medium for transfection.  
c. Simultaneous delivery of two different fluorescent protein coding genes into cells 
With optimal combined medium for transfection, I tested second strategy to knock-in 
EGFP and hKO gene into specific location. I simultaneously delivered two different 
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fluorescent protein coding genes into cells. Two days after transfection, the transfected cells 
become fluorescent. The single-color ESCs were removed by sequential selections with 
puromycin and zeocin to obtain EGFP+/hKO+ ESC colonies (S site: Fig. 7A and T site: Fig. 
8A).  
These mESC clones that expressed two fluorescent signals in second method were 
also collected (Fig. 7B and 8B). Recombination was confirmed by polymerase chain reaction 
(PCR) analysis of their genome DNA (Fig. 7C and Fig. 8C) with different primer sets as 
shown in red arrows in Fig. 4A, 4B and Fig. 5A, 5B. On S site, among the isolated 50 clones, 
33 clones that grew well were genotyped, and most of the isolated clones had the inserted 
gene(s) at the S site (Primers: a+b). However, only five ESC clones (No. 20, 21, 29, 36, and 
40) had the EGFP and hKO gene at each S site on the X chromosome while other clones had 
only the EGFP gene or hKO gene on both X chromosomes (Primers: a+c, a+d) (marked in 
red). These results indicated heterozygous female mESCs (EGFP+/hKO+) has been 
established (Fig. 7C). In addition, to further confirm non-specific integration of neither EGFP 
nor hKO, DNA genome from these five clones were also used as template for PCR analysis 
with primers on targeting vectors and EGFP or hKO sequences (Fig. 7D). Two out of five 
clones, (clone No. 20 and No. 29, hereafter called “S20” and “S29”) showed single copy of 
fluorescent reporter genes at targeted site (Fig. 7D). Similarly, on T site, I also established 
EGFP+/hKO+ mESCs which carry single copy of fluorescent reporter genes at targeted site 
(clone No. 36, hereafter called “T36”) (Fig. 8). Conclusively, at each site, I successfully 
generated heterozygous EGFP+/hKO+ mESCs (S site: S20 and S29, T site: T36). These clones 
were used for my further experiments. 
d. Generation of negative selection marker containing EGFP+/hKO+ mESCs 
In this study, I aim to establish system to monitor X chromosome reactivation during 
reprogramming and further investigate XCR mechanism. For more convenient monitoring, I 
collect single-color differentiated cells. Moreover, it is difficult to achieve XCI completely 
without any remained undifferentiated cells. Therefore, a strategy for selecting single-color 
cells without contaminated undifferentiated cells is developed. In this study, I tested negative 
selection by Thymidine kinase (TK) gene. For that purpose, I aim to establish mESC clones 
whose one allele carry EGFP coding gene together with TK gene, another allele carries hKO 
gene. During differentiation, negative selection with Ganciclovir will be performed to remove 
TK+ cells. Therefore, only hKO+ differentiated cells (TK- cells) were selected for 
reprogramming (Fig. 9A). TK gene is constructed together with puromycin resistance gene in 
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EGFP targeting vector (pEF1-EGFP-IP.TK targeting vector) (Fig. 9B and 9C).  Unexpectedly, 
female mESCs being transfected EGFP-IP.TK targeting vector showed weak fluorescent 
signal and could not survive under puromycin and zeocin selection during transfection (Fig. 
9D and 9E). Knock-in of TK gene into mESCs might be harmful for cells.  
2.3.2 Detection of X chromosome inactivation during differentiation 
The integration site of a reporter is important if I are about to monitor X chromosome 
inactivation (XCI) because some genes on X chromosomes are known to escape from XCI 
process. In order to evaluate XCI subjection of the inserted reporter gene, three candidate 
mESC clones are differentiated through embryoid bodies (EBs) and observed changing of 
fluorescent signal in monolayer cells as shown in Fig. 10A. At mESC stage, initial cells are 
expected to express double signals, implying 2 active X chromosome. Upon differentiation, 
at EB stage, they generate chimeric cluster of cells displaying either green or orange 
fluorescence. EB-derived cells express only one of the two fluorescent proteins (EGFP+ or 
hKO+). In my established candidate clones (S20, S29 and T36), they initially showed double 
fluorescent pattern at mESC stage, chimeric pattern at EB stage and expressing either green 
or orange pattern at single cell state (Fig. 10B and Fig. 10C). This indicated that the inserted 
fluorescent protein genes are subjected to X chromosome inactivation in live cells. It also 
confirmed there is no random integration of EGFP or hKO along genome, which are 
consistent with random integration confirmation in Fig. 7D and Fig. 8D. The silencing is 
initiated by the long noncoding RNA, X inactive specific transcript (Xist), which coats Xi. 
The Xist gene is exclusively expressed in inactive X chromosome (Xi) and accumulates 
within the territory of the Xi. Therefore, I further confirmed XCI in monolayer cells by 
checking expression of Xist. During differentiation from ESCs to monolayer cells with 
transient EBs, Xist were significantly increased (Fig. 10D). Xist expression confirmed 
inactive X chromosome (Xi) status. Taken together, these results suggested that these cells 
enable monitoring of XCI by the fluorescent signals in live cells. 
Moreover, XCI process in T site EGFP+/hKO+ cells occurred earlier than S site cells. 
This observation might be resulted from insertion location. As I showed insertion sites for 
each site in Fig. 2, T site is closer to Xist than S site, hence, XCI might proceed faster in T site. 
Notably, during XCI process, some somatic cells differentiated from the T36 clone were 
found to lose expression of both EGFP and hKO (marked in white dot line), suggesting that 
the gene inserted into the T site may be repressed independent of XCI and monitoring of XCI 
is affected by insertion site. Taken together, these results indicate that the fluorescent protein 
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genes driven by the human EF-1α promoter are subject to XCI even when inserted into 
intergenic sites of the X chromosome, and the fluorescent genes at the S site may be more 
suitable than those at the T site for observing XCI. Therefore, I will focus on S site clone in 
further experiments. Summary of these clones is described in Table 5. 
2.3.3 Detection of X chromosome reactivation during reprogramming 
For further observation or tracking X chromosome reactivation (XCR), I collect hKO+ 
cells derived from S29 ESC clone for reprogramming. As shown in Fig. 11A, I induce 
EGFP+/hKO+ mESCs to differentiate through embryoid bodies (EBs). Then, EBs will be 
suspended into single cells. hKO+ differentiated cells will be isolated by zeocin. hKO+ cells 
are reprogrammed into iPSCs. iPSCs display two fluorescent signals, indicating XCR upon 
reprogramming.  
After isolating hKO+ differentiated cells, quantitative RT-PCR was performed to 
check differentiation status. The result showed significantly reduced level of pluripotency 
marker gene (Oct4) and increased level of differentiation marker genes (Cdh2, Tgfb1) (Fig. 
11B). These data implied that hKO+ cells were undergone XCI, maintained one active X 
chromosome (XaXi).  
2.3.3.1 Effect of medium component on XCR observation 
XCR is a reversal process of inactivation which is occurred during reprogramming. 
To examine whether establishing system could be used for detecting XCR in vitro or not, I 
induced iPSCs from hKO+ cells (XahKOXiEGFP cells) by infecting SeVdp(KOSM), which 
express 4 Yamanaka factors (Klf4, Oct4, Sox2 and c-Myc). Different stem cell laboratories 
rely on different culture conditions to support the expansion and maintenance of pluripotent 
stem cells. Culture of stem cells under undefined conditions are not able to enhance 
pluripotency of stem cells. Hence, it might affect to my observation during reprogramming. 
Therefore, I first tested effect of medium components on XCR observation. I used two 
different media (Serum-free medium: 2i medium and Standard serum containing medim with 
LIF: ES medium) for culturing reprogramming cells. Following reprogramming, fluorescent 
signal is monitored to track XCR (EGFP reactivation - XahKOXaEGFP). In 2i medium, around 
day 15 of reprogramming, colonies reprogrammed from hKO+ cells started to show 
heterogenous pattern of double signal, indicating partial XCR. Around day 17, I observed 
homogenously double-colored colonies, indicating completed XCR (Fig. 11C). In standard 
serum-containing medium with LIF, initiation of XCR timepoint was slightly delayed. It also 
could not support completed XCR, only heterogeneously double-colored colonies were 
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formed. Moreover, compact round shape colony is a well-known marker for distinguishing 
naïve and primed pluripotent stem cells. Serum-free medium (2i medium) maintained 
reprogrammed colonies in rounder shape than serum medium. Therefore, in the purpose of 
using fluorescence as an indicator for high quality iPSCs as well as for more convenient 
observation, I decided to use serum-free medium during reprogramming.  
I further determined whether SeV infected cells were successfully reprogrammed by 
checking expression of pluripotency genes (Cdh1, Oct4, Rex1). These genes were 
upregulated during iPSC generation and showed similar expression level of mESCs. 
Especially, Rex1, a marker for high quality PSCs, expressed as high as mESCs (Fig. 11E). I 
also evaluated Xist expression to confirm X chromosome status in generated iPSCs since 
XCR occurs after silencing of Xist RNA [79]. Xist expression was significantly decreased in 
iPSCs although its expression was still detected (Fig. 11F). Since population of generated 
iPSCs is heterogenous, it is hard to detect Xist silencing completely. The downregulation of 
Xist is sign for XCR. Conclusively, my system could be used for detecting XCR during 
reprogramming.  
2.3.3.2 Correlation between pluripotency and XCR 
Using this system, it is obvious to observe heterogeneity of reprogrammed cells. In 
population of reprogrammed colonies, some colonies showed homogenous or heterogenous 
pattern of double signal, some of them maintained orange signal. I obtained iPSC colonies 
reprogrammed from hKO+ somatic cells that were derived from S site ESCs, that were 
morphologically indistinguishable but nonetheless showed different expression patterns of 
EGFP. Fig. 12A shows fluorescent pattern of picked-up colonies in reprogrammed population. 
It indicated that XCR has not occurred simultaneously in all formed colonies.  
Additionally, in 2014, Pasque et al showed XCR occurred at late phase of 
reprogramming. In this study, Nanog+ cells exhibited biallelic expression of X linked genes, a 
sign of XCR. Therefore, reactivation of X chromosome is closely linked to pluripotency or 
quality of iPSCs. In order to examine the relationship between XCR and pluripotency, 
expression level of pluripotency marker genes was determined in different miPSC clones (Fig. 
12B). Interestingly, I found out correlation between pluripotency and XCR pattern. Clones 
maintaining orange signal expressed lower level of pluripotency marker genes than 
heterogenous or homogenous pattern of double fluorescent signals (Fig. 12B). It indicated 
XCR is correlated to pluripotency.  
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In particular, I found out that homogenously double-colored iPSCs (iPSC clone #6), 
which indicated completed XCR, showed higher Rex1 expression (a marker for high 
pluripotency stem cells) than heterogeneously double-colored (#3) or orange iPSCs (#20) 
(Fig. 12C). Xist expression were also determined to gain more evidences on difference on 
XCR process between these iPSC clones. Expectedly, I found correlation between Xist 
expression level and pattern of fluorescence in iPSC clones. Xist is significantly repressed in 
homogenously double-colored iPSCs (iPSC #6) compared to heterogenous double-colored 
iPSC clone or orange clone (Fig. 12D). Xist expression was consistent with Rex1 expression 
level between iPSC clones. This data further confirmed correlation between XCR and 
pluripotency. Although further experiments should be done to confirm pluripotency of 
generated double-colored iPSCs in vivo, this system provides simple methods for detecting 
heterogeneity of reprogramming cells’ population and isolating high and low quality iPSC by 
monitoring XCR during reprogramming.  
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Figure 1. Detection system of X chromosome inactivation (XCI) and reactivation (XCR) 
Two different fluorescent reporter genes (EGFP and hKO) are inserted into X chromosomes 
of female mESCs. Before differentiation, mESCs express double (EGFP and hKO) 
fluorescence from their two active X chromsomes (XaXa).  Upon differentiation, they 
express either orange or green signal due to XCI, which occurs randomly in one of the two X 
chromosomes. During reprogramming, which is reverse process of differentiation, the 
inactive X chromosome is reactivated by the process termed X chromosome reactivation 
(XCR), which can be monitored by the presence of two fluorescence signals.  
 
 
Figure 2. X chromosomal locations where fluorescent protein coding genes were 
inserted 
Two sites on the X chromosome were used for insertion of reporter genes encoding 
fluorescent protein markers. Intergenic regions close to Syap1 (S site) and Taf1 (T site) were 
chosen. Guide RNAs (gRNAs) for targeting each site were also shown. 
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Figure 3. Validation of gRNA efficiency. Cas9-gRNA expression vectors and validation 
vectors (pCAG-EGxxFP) containing the corresponding gRNA target sequence were 
transfected into HEK293 cells. The efficiency of targeting the two sites by each gRNA is 
validated by EGFP expression. Scale bars: 100µm. 
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Cas9-gRNA vector (µg) 
     Targeting vector (µg) 
0.5 
  0.25 
0.5 
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L. 
 Number of 
EGFP+/hKO+ colonies 
pX330-hCas9 
phEF1-hKO-IZ-Syap1 
446 
pX330-hCas9-gRNA 
phEF1-hKO-IZ-Syap1 
441 
Figure 4. Generation of mESCs that possess EGFP+ and hKO+ at the S site. (A) EGFP 
targeting vector for the S site. (B) hKO targeting vector for the S site. Each targeting vector 
carried a fluorescent protein gene and a drug-resistant gene between the homologous 
sequences in the targeted site. Expression of fluorescent protein coding genes and drug-
resistant genes was driven by the EF1α promoter. (C) Scheme for establishing EGFP+/hKO+ 
mESCs by a step-by-step method. Female mESCs were transfected with the Cas9/gRNA 
expression vector and EGFP targeting vector. EGFP+ clone with validated EGFP insertion in 
one allele were used for transfection with the Cas9/gRNA expression vector and hKO 
targeting vector. Double-positive (EGFP+/hKO+) colonies were collected, and hKO insertion 
into the other allele was confirmed. (D) (E) Effect of the amount of the targeting vector on 
the efficiency of generating mESCs with the knocked-in fluorescent protein coding gene. 
Female mESCs were transfected with various amount of the Cas9/gRNA expression vector. 
The numbers of EGFP+ colonies were compared among different groups to evaluate the 
effect of plasmid amounts on the efficiency of knocking-in the EGFP coding gene into 
mESCs. (F) EGFP+ mESC generation. Two days after transfection, puromycin was added to 
select for puromycin-resistant mESCs. (G) Colonies with green fluorescence were picked up 
and PCR analysis was performed to confirm the correct genome editing in these colonies. 
The positions of the primer sets are shown by red arrows in (A) and (B). The clone with the 
targeted insertion is marked in red. (H) EGFP+/hKO+ mESC generation. Candidate clones 
(marked in red color – No. 19) were used for a second transfection with the Cas9/gRNA 
expression vector and hKO targeting vector. Two days after transfection, zeocin was added to 
select for zeocin-resistant mESCs. (K) Double-colored mESC clones were collected and 
analyzed to confirm the insertion of the hKO-coding gene by the indicated primer sets. (L) 
The number of double-colored colonies that survived zeocin selection after the second 
transfection. The colony numbers were counted for the mESCs transfected with or without 
gRNA. Scale bars: 100µm. 
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pX330-hCas9 
phEF1-hKO-IZ-Taf1 
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pX330-hCas9-gRNA 
phEF1-hKO-IZ-Taf1 
187 320 213 
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Figure 5. Generation of mESCs that possess EGFP+ and hKO+ mESCs at the S site. (A) 
EGFP targeting vector for the T site. (B) hKO targeting vector for the T site. Each targeting 
vector carried a fluorescent protein gene and a drug-resistant gene between the homologous 
sequences in the targeted site. Expression of fluorescent protein-coding genes and drug-
resistant genes was driven by the EF1α promoter. (C) (D) Effect of the amount of the 
targeting vector on the efficiency of generating knocked-in fluorescent protein-coding gene. 
Female mESCs were transfected with various amount of the Cas9/gRNA expression vector 
and EGFP targeting vector. The numbers of EGFP+ colonies were compared between 
different groups to evaluate the effect of plasmid amount on the efficiency of knocking-in the 
EGFP coding gene into mESCs. (E) EGFP+ mESC generation. Two days after transfection, 
puromycin was added to select for puromycin-resistant mESCs. (F) Colonies with green 
fluorescence were picked up and PCR analysis was performed to confirm the correct genome 
editing in these colonies. The positions of the primer sets are shown by red arrows in (A) and 
(B). The clones with the targeted insertion were marked in red. (G) EGFP+/hKO+ mESC 
generation. Candidate clones (marked in red color – No. 34, 40, 43) were used for a second 
transfection with the Cas9/gRNA expression vector and hKO targeting vector. Two days after 
transfection, zeocin was added to select for zeocin-resistant mESCs. (H) Double-colored 
mESC clones were collected and analyzed to confirm the insertion of the hKO-coding gene 
by the indicated primer sets. (K) The number of double-colored colonies that survived zeocin 
selection after the second transfection. The colony numbers were counted for the mESCs 
transfected with or without gRNA. Scale bars: 100µm.  
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- Neurobasal medium 
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- LIF 
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- LIF 
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  + 
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Number of EGFP+/hKO+ colonies 
+ gRNA - gRNA 
2i 20 0 
E 107 16 
E+2i(s) 423 51 
50/50 148 10 
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 Picked up 
colonies 
Survival 
clones 
Clones with 
targeted insertion 
on both alleles 
Targeting 
efficiency (%) 
2i 20 0 0 0% 
E 50 25 1 2% 
E+2i(s) 50 40 2 4% 
50/50 50 34 5 10% 
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Figure 6. Effect of medium components on generation of EGFP+/hKO+ mESCs. (A) Four 
different media were tested. Components of each medium are listed. (B) Female mESCs were 
transfected with the Cas9/gRNA expression vector and two different S site-targeting vectors. 
The transfected cells were cultured in different medium and selected sequentially by 
puromycin and then by zeocin. (C) Morphology and fluorescent pattern of transfected 
colonies after 4 days of transfection. (D) Number of double-colored colonies after puromycin 
selection. The colony number were counted on samples transfected with and without gRNA. 
(E-G) Double-colored colonies were picked up and continuously cultured in these media 
together with zeocin. Surviving clones were collected and analyzed to validate the correct 
recombination on the targeted chromosome. The clones were cultured in different medium – 
E, E+2i(s) and 50-50 medium as shown in (H). Clones with the expected insertion were 
marked in red. (H) Summary of the targeting efficiency of cells cultured in different medium. 
Scale bars: 100µm. 
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Figure 7. Generations of S site EGFP+/hKO+ mESCs by the simultaneous delivery 
method. (A) Scheme for establishing EGFP+/hKO+ mESCs. Female mESCs were transfected 
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with the Cas9/gRNA expression vector and two different targeting vectors. The transfected 
cells were then selected by puromycin and zeocin. (B) Transfected mESC colonies expressed 
double fluorescence (EGFP+/hKO+) after drug selection. (C) Genomic PCR analysis of the 
fluorescent protein gene inserted at the specific site of isolated clones. Primer sets used in 
analyses are shown in Figs. 4A and 6B. Clones with the expected insertion are marked in red. 
(D) Confirmation of non-specific insertion. Different primer sets were used to detect random 
integration of the EGFP or hKO gene into the genome of isolated clones. Scale bars: 100 µm. 
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Figure 8. Generations of T site EGFP+/hKO+ mESCs by the simultaneous delivery 
method. (A) Scheme for establishing EGFP+/hKO+ mESCs. Female mESCs were transfected 
with the Cas9/gRNA expression vector together and two different targeting vectors. The 
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transfected cells were then selected by puromycin and zeocin. (B) Transfected mESC 
colonies expressed double fluorescence (EGFP+/hKO+) after drug selection. (C) Genomic 
PCR analysis of the fluorescent protein gene inserted at the specific site of isolated clones. 
Primer sets used in each analyses are shown in Figs. 4A and 6B. Clones with the expected 
insertion are marked in red. (D) Confirmation of non-specific insertion. Different primer sets 
were used to detect random integration of the EGFP or hKO gene into the genome of isolated 
clones. Scale bars: 100 µm. 
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Figure 9. Generation of negative selection marker containing EGFP+/hKO+ mESCs. (A) 
(A) In order to observe XCI, double-colored mESCs were allowed to differentiate. In a 
population of differentiated cells, some cells remained undifferentiated. Negative selection 
(thymidine kinase (TK) selection) was done during differentiation to remove double-colored 
cells and isolate single-color cells (hKO+ cells), which were then used for further 
reprogramming. Ganciclovir was added to the differentiated cells to remove TK+ cells and 
select only hKO+ (TK-) cells for reprogramming. (B) (C) Structure of the thymidine kinase 
targeting vector for each site. The puromycin resistance gene in the EGFP targeting vector 
was replaced by the puromycin resistance gene (pEF1-EGFP-IP.TK targeting vectors). (D) 
Morphology and fluorescent pattern of transfected colonies after puromycin and zeocin 
selection, at the S and T site, respectively. Scale bars: 100µm.  
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Figure 10. Detection of X chromosome inactivation (XCI) during differentiation. (A) 
Scheme of ESC differentiation and induction of XCI. mESC clones, which express double 
fluorescence (EGFP+/hKO+), were differentiated via embryoid body (EB) formation. At the 
EB stage, the cells showed a heterogeneous pattern of fluorescent signals. Subsequently, EB-
derived cells formed monolayer and ceased to one of the two fluorescent proteins (EGFP+ or 
hKO+), indicating X chromosome inactivation (XCI) during differentiation. (B) (C) 
Fluorescent patterns of selected clones. White dotted line indicates that monolayer cells 
derived from T36 ESC clone lost expression of both EGFP and hKO (D) Xist expression at 
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each stage of selected clones. Data represent means ±SEM of three biologically independent 
experiments. * p < 0.05, ** p < 0.01, *** p < 0.001. Scale bars: 100µm.  
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Figure 11. Detection of X chromosome reactivation during reprogramming. (A) Scheme 
of iPSC generation to detect XCR. The hKO
+ somatic cells were collected from a population 
of monolayer cells by zeocin selection. iPSCs were generated from hKO
+
 EB-derived cells by 
using SeVdp(KOSM). After the start of reprogramming, live cells were monitored 
continuously by fluorescence to detect XCR. Some of the iPSC colonies displayed double 
(EGFP
+
/hKO
+
) fluorescence, indicating that XCR occurred during iPSC generation. (B) 
Expression of pluripotency (mOct4) and differentiation markers (Cdh2, Tgfb1) in hKO+ 
somatic cells. (C) (D) Effect of different media on detection of X chromosome reactivation. 
During reprogramming of isolated hKO+ differentiated cells, Sendai virus-infected cells were 
cultured in serum-free medium (2i medium) or standard serum-containing medium with LIF 
(ES medium). (E) Expression of pluripotency markers (Cdh1, mOct4, Nanog) of generated 
iPSCs cultured in 2i medium. (F) Expression of mXist of generated iPSCs cultured in 2i 
medium. * p < 0.05, ** p < 0.01, *** p < 0.001. Scale bars: 100µm. 
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Figure 12. Detection of a heterogeneous population of iPSCs. (A) Different fluorescent 
patterns of iPSC clones were observed in a population of reprogrammed cells. iPSC colonies 
with different fluorescent patterns were picked up. Three representative clones were shown 
(#20, #3, #6). (B) Correlation between the expression levels of pluripotency marker genes 
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and the patterns of fluorescent protein expression. Representative markers (mOct4, Esrrb, 
Nanog) were shown. (D) Rex1 expression in iPSCs with different fluorescent patterns. (H) 
mXist expression in iPSCs with different fluorescent patterns. Data represent means ±SEM of 
three biologically independent experiments. * p < 0.05, ** p < 0.01, *** p < 0.001. Scale 
bars: 100µm. 
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2.4 Discussion 
2.4.1 Generation of EGFP+/hKO+ mESCs  
❖ Effect of gRNA sequence on homologous recombination 
In the current study, my goal was to establish a novel cell line that permits live cell 
imaging system of XCR during reprogramming and further analyze the mechanism of XCR. 
For this purpose, I aimed to establish female mESC lines that carry reporter genes on both X 
chromosomes and chose EGFP and hKO as fluorescent markers. These two fluorescent 
proteins have distinct emission wavelengths with minimal overlap, enabling identification of 
cells that express one or both fluorescent proteins under microscopy. These fluorescent 
proteins should be inserted into the same positions of both X chromosomes, so that the effect 
of chromosome position on their expression levels could be minimized. This would enable 
easy identification of XCI during differentiation and XCR during reprogramming at a single-
cell level without using any invasive methods. 
To do this, several genome-engineering techniques were taken into consideration. Zinc-
finger nucleases (ZFN) and transcription activator-like effector nucleases (TALEN) have 
opened the window for mammalian genome engineering. The system utilizes the DNA 
sequence-specific binding of each zinc-finger domain that contains specific amino acid 
residues in it. By combining four zinc-finger domains in tandem, one could make a factor that 
binds to the specific position within the genome. By attaching a nuclease to this tandem 
repeats of the zinc finger domains, it is possible to make an enzyme that binds to a specific 
genome position and induce a targeted DNA double strand breaks (DSB), which stimulates 
error-prone nonhomologous end joining (NHEJ) or HR. However, difficulties in designing 
these enzymes and complexity in preparing them prevent its widespread use.  
Recently, the CRISPR/Cas9 system has been widely used for genome editing to 
generate genetically modified organisms or cells to study the function of genes or their 
regulatory mechanisms. The CRISPR/Cas9 system allows a simple, easy, and inexpensive 
way to edit the genome with an unprecedented flexibility and specificity. The specificity of 
targeting the genome is conferred by the sequence of a guide RNA (gRNA), which, as 
compared to four tandem repeats of zinc finger domains, enables far more flexible and 
specific targeting. In a genome targeting, it is possible to test different gRNAs and choose the 
one with the highest efficiency. In my initial experiment, I tested several different gRNAs to 
find their targeting efficiency. Expression levels of EGFP, which is reconstituted by 
homologous recombination after gRNA-mediated DNA cleavage, were different among the 
testes gRNAs. Having a look back at these gRNA sequences, I found that 20-bp genome 
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target of gRNA1 and gRNA5, which showed the strongest EGFP expression, starts with the 
base guanine (G). This G base is part of the promoter sequence required for the initiation of 
transcription of human U6 promoter. Bases other than G at the 5’ end of a gRNA may affect 
transcription efficiency of the U6 promoter, which may lead to low gRNA expression and 
lower efficiency of gRNA-mediated DNA cleavage. 
❖ Position of knock-in reporter genes 
XCI are known to occur not uniformly throughout the X chromosome, and some X-
linked genes are known to escape XCI. Furthermore, spreading of silencing along the X 
chromosome depends on the three-dimensional conformation of X chromosome during XCI 
in vitro [107]. This suggests that the position of a reporter gene within the X chromosome can 
influence monitoring of XCI. Therefore, the integration site of the fluorescent genes is 
important if XCI is to be monitored accurately. In this project, I chose two different sites as 
integration sites that fulfilled the criteria: 1) the site is within an intergenic region, 2) the 
surrounding genes are expressed ubiquitously, and 3) the surrounding genes are subject to 
XCI. I chose two sites close to the Syap1 or Taf1 gene and inserted two different fluorescent 
genes into each allele of the X chromosome. Each site is located in the intergenic region, 
surrounded by genes that show ubiquitous expression throughout all developmental stages 
(intergenic regions for insertion are shown in Fig. 2). At the ESC stage, generated T site 
EGFP+/hKO+ mESC clones showed unstable expression of fluorescence, which indicates that 
the pluripotency of ES cells may be also unstable despite the indistinguishable morphological 
features. The T mESC clones could not maintain their pluripotency for long-term culture and 
could not survive well under drug selection, as compared with the S clones. It might be that a 
gene inserted at the T site may be subject to silencing independent of XCI. It could also be 
possible that the T site is subject to XCI earlier than the S site since the T site is closer to the 
Xist gene or X chromosome inactivation center (XIC). Moreover, I observed half of cells 
express neither EGFP nor hKO gene in the T clones during differentiation. This may indicate 
the intrinsic instability of expression of the gene at the T site.  
❖ Delivery methods of reporter genes 
In this study, I tested two kinds of strategies to introduce desired inserts into X 
chromosomes. The first strategy is a step-by-step method, by which mESC clones harboring 
the EGFP gene in one allele of X chromosome were isolated and then used to insert the hKO 
gene into the other allele. The second strategy is a simultaneous delivery method, by which 
two different fluorescent protein-coding genes were inserted into mESCs simultaneously in a 
single transfection experiment. In the first strategy, hKO insertion can be identified by 
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observing double-colored colonies after the second transfection. PCR analysis with primers 
detecting the full length of insertion showed that the initial EGFP heterozygous mESCs 
became EGFP homozygous ones instead of having both EGFP and hKO, indicating that the 
hKO gene could not be inserted into the second allele at either T or S site. This phenomenon 
may be because the homologous recombination between two X chromosomes occurs more 
readily than that between the X chromosome and the donor template plasmid: The second 
allele, which is the uninserted allele after the first transfection, tends to use the edited allele, 
where the EGFP has been inserted, as a template for homology-based repair rather than the 
free hKO donor template plasmid. The much longer homologous regions and proper 
alignment of two X chromosomes may prevent the donor template plasmid to function as a 
repair template despite the much higher copy number of the donor template. It may also 
explain the much higher number of single-colored mESCs possessing only EGFP or hKO on 
both X chromosome. In any case, I succeeded in generating EGFP+/hKO+ mESCs using the 
second strategy. Thus, it is recommended to use the simultaneous delivery method when two 
different fluorescent genes are inserted into the same locus of two chromosomes.  
❖ Effect of cell culture medium on genome editing efficiency 
Different stem cell laboratories rely on different methods to support expansion and 
maintenance of mESCs. Culture of stem cells under inappropriate conditions can induce their 
differentiation and reduce reproducibility of experiments. In recent years, new ES cell culture 
protocols, using better-defined conditions, have been published. 2i medium containing two 
small molecule inhibitors (CHIR99021 and PD0325901) is proven to be the standard 
condition for culturing ESCs. However, 2i medium renders ESCs more resistant to 
transfection, perhaps due to the densely packed ESCs within colonies formed under this 
condition. Another drawback of 2i medium is its high cost. Therefore, I tested the 
transfection efficiency, using different media (2i medium; E medium: DMEM+KSR+LIF; 
E+2i(s) medium: E medium + 2 inhibitors; 50/50 medium: combination of 2i and E medium). 
In the experiments targeting the S site, ESCs responded differently to different media. The 
numbers of double-colored colonies after transfection varied between different media. 2i 
medium seems to prevent random integration of the targeting vector, which occurs 
independent of gRNA, outside the targeted S site. However, this medium was too severe for 
the transfected cells to survive, and most of the cells died. When E+2i(s) was used, by 
contrast, a higher number of double-colored colonies were obtained. However, it resulted in a 
higher percentage of colonies with random integration. When the 50/50 medium was used, 
the targeting efficiency was higher than those observed when other media were used. 
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Observation of the cells during transfection and selection, the 50/50 medium supported 
reasonably good growth of transfected colonies while maintaining round shapes and 
fluorescent signals. The combination of the 2i medium and E medium may have retained the 
properties of both media; to maintain ESCs in the naïve state by the 2i medium and to support 
fast cell expansion by the E medium. 
❖ Effect of reporter genes’ structures 
Previous studies showed that the CAG promoter inserted in the X chromosome is 
subjected to XCI and completely inactivated at post-implantation stages [81], showing that 
the CAG promoter does not interfere with XCI and thus can be used for monitoring XCI 
using a CAG promoter-driven gene. Different promoters have different abilities to express 
the reporter gene depending on the stage of development and type of cells [108]. The EF1α 
promoter is known to show high transcriptional activities in either ESCs or EBs, and in my 
project, I tested the EF1α and CAG promoters to drive the expression of reporter genes. In 
female mESCs, the EF1α promoter appeared to show a stable activity than the CAG promoter 
(data not shown). Therefore, I used the EF1 promoter to express the inserted reporter genes 
on the X chromosome. 
In order to collect single-color differentiated cells for further monitoring XCR during 
reprogramming, I differentiated EGFP+/hKO+ mESCs into monolayer cells. Upon 
differentiation, the cells expressed either green or orange fluorescent signal. However, a 
population of differentiated cells contained undifferentiated double-colored cells. Since these 
double-color cells grew faster than single-color ones, they may obscure XCR observation 
during reprogramming. To overcome this, the thymidine kinase (TK) gene was placed in the 
vector together with the puromycin resistance gene in the EGFP targeting vector (EGFP-
IP.TK). During differentiation, negative selection with Ganciclovir was attempted to remove 
TK+ cells so that only hKO+ differentiated cells (TK- cells) could be selected for 
reprogramming. Unexpectedly, female mESCs transfected with the EGFP-IP.TK targeting 
vector showed a weak fluorescent signal and could not survive under puromycin and zeocin 
selection after transfection. Knock-in of the TK gene into mESCs might be harmful for some 
unknown reasons.  
2.4.2 3S reprogramming system for analyzing mechanism of XCR 
Several reports indicated that the efficiency of reprogramming, occurrence of XCR as 
well as the characteristics of iPSCs are influenced by the expression levels and stoichiometry 
of reprogramming factors. Our group has developed a stage specific reprogramming system 
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(3S system), which generated a series of iPSC populations with distinct degrees of 
reprogramming. A Sendai virus vector termed SeVdp (fK-OSM), in which KLF4 is tagged N 
terminally with a destabilization domain (DD), facilitates degradation of KLF4 and decreases 
its expression level. Because a small chemical termed Shield1 regulated the degradation of 
KLF4 by the DD, adding different concentrations of Shield1 to cell culture medium allows 
generation of paused iPSCs at specific time points of reprogramming in a reproducible and 
predictable manner. The paused iPSCs are stable and retain the ability to resume 
reprogramming after a long period time in the cell culture. According to our group’s 
published paper, the pause iPSCs are relatively homogeneous and phenotypically stable, and 
free from silencing of transgenes [109]. Thus, this system has a significant advantage for 
further analyzing the process of reactivation of X chromosome in iPSC generation, using the 
differentiated cells obtained from double-colored ESCs.  
2.4.3 XCR and acquisition of pluripotency 
Around day 15 after SeV infection, EGFP+/hKO+ colonies started to appear from 
XahKOXiEGFP differentiated cells that were infected with SeVdp(KOSM)., showing that XCR 
occurs at this time point. As colonies showed different patterns of fluorescence expression, I 
used RT-qPCR to investigate expression of pluripotency marker genes and Xist expression 
and found a correlation between XCR and pluripotency. The cells that have undergone 
complete XCR (homogenously double signal) showed higher expression of pluripotency 
marker genes. This result provides evidence that tracking XCR could help to distinguish 
between low and high qualities of iPSCs.  
In 2014, Pasque et al showed XCR is a very late event of reprogramming that occurs 
after Xist RNA coating has disappeared and occurs only after the expression of Nanog. Later 
in reprogramming, Nanog+ cells showed biallelic expression of X-linked genes, which 
indicate XCR. In Pasque’s experiment, they used FISH analysis of single cells to detect 
expression of the Xist RNA and chose some specific genes on the X chromosome. There are 
thousand genes along the X chromosome, and therefore, whether only detecting the 
reactivation of some specific genes is sufficient to indicate reactivation of the whole X 
chromosome. If XCR does not occur simultaneously at these genes, it is possible that some 
genes can be reactivated before or after the acquisition of pluripotency. Therefore, to 
understand the mechanism of XCR more clearly and its relationship to the acquisition of 
pluripotency, it is essential to investigate where XCR initiates and how XCR spreads along 
the entire X chromosome. 
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As mentioned above, different stem cell laboratories depend on different methods to 
expand and maintain mESCs or pluripotent stem cells. Culture of stem cells under different 
conditions can elicit different states of XCI or XCR. In my own experiments, two different 
media (2i medium and standard serum-containing medium with LIF) were used to culture 
iPSCs during reprogramming. Appearance of XCR was obviously affected by the choice of 
medium. In the 2i medium, initiation of XCR occurred around day 15 after SeVdp(KOSM) 
infection and soon proceeded to completed XCR with appearance of many colonies with 
homogenous double-color fluorescence. However, in the standard serum-containing medium 
with LIF, initiation of XCR was delayed as compared to cells culture in the 2i medium, and 
these colonies showed only heterogeneously double-colored fluorescence. Moreover, a 
compact and round shape of colonies is a well-known marker for distinguishing naïve and 
primed pluripotent stem cells. Serum-free medium (2i medium) maintained reprogrammed 
iPSC colonies in rounder shape than serum medium. The use of fluorescence as an indicator 
for XCR and high-quality iPSCs is not only convenient but also reveals a difference between 
different media and iPSC colonies, which otherwise would be very difficult to observe. 
2.4.4 Future application of XCR research 
My live imaging approach of ESCs/iPSCs will help us to follow cell derivation and 
observation of the X chromosome status, which changes during culture of these cells in vitro. 
With the precise observation of the X chromosome status in vitro, it is possible to investigate 
the mechanisms of XCI and XCR in vivo. 
During normal development, only early embryonic cells and germ cells undergo XCR, 
and this process is a rare event in vivo [39]. However, abnormality of XCI increases with 
aging and in cancer cells, presumably due to the improper maintenance of XCI [68] [110] 
[111], and reactivation of X chromosome might occur in other events as well. It is worth 
evaluating whether cells undergo XCR during development, aging, tumorgenesis, and 
dedifferentiation in a whole organism. It would be interesting to explore the prevalent 
characteristics between newly discovered cells undergoing XCR, as they could be a new type 
of pluripotent stem cells. Analysis of these cells enable us to clarify the mechanism and 
biologically important role of the reactivation of inactive X chromosome in vivo. 
In the ICM of a human embryo, XCR is also observed, suggesting that it could be 
used as a marker to distinguish naïve PSCs from primed PSCs [112]. Therefore, my live cell 
imaging system of XCR enables us to improve culture conditions for human naïve PSCs.  My 
established system also contributes in analyzing genomic reprogramming which would help 
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us to investigate the biology of naïve cells in order to maintain its pluripotent state stably. 
Furthermore, it also enables us to clarify or establish an effective system to convert primed 
human ESCs to of naïve iPSCs.  
In summary, my work establishes a novel system for visualizing the X chromosome 
status in live cells in vitro. Generated female EGFP+/hKO+ mESC lines can be utilized for 
tracking XCI upon differentiation and/or monitoring XCR during reprogramming. The 
detection system of XCR during reprogramming provides a simple method for isolating high-
quality iPSCs, which will be a promising material for regenerative therapy research. My data 
suggest that this system also provides an important tool for tracing the reprogramming 
process and clarifying how XCR participates in this process. It also will help to clarify how to 
convert/rescue primed cells to naïve cells. This clarification will help me to effectively 
establish a novel method to convert primed human ESCs to naïve iPSCs. Although my initial 
results have just pointed out the time point of reactivation, this finding enables scientists to 
move closer to understand the molecular mechanism that underlies reprogramming. 
Moreover, establishment of cell lines which were generated by using a new technique 
CRISPR/Cas9 has built a new storage of cell lines which are useful in XCI or XCR related 
experiments. 
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Chapter III. Conclusions and Perspectives 
3.1  Conclusions 
My work reveals a novel system for visualizing X chromosome status in live cells in 
vitro. Generated female EGFP+/hKO+ mESC lines can be utilized for tracking XCI upon 
differentiation and/or monitoring XCR during reprogramming.  
My data also pointed out correlation between XCR and pluripotency. The completed 
XCR iPSCs also expressed higher level of Rex1 than partial XCR iPSCs. Xist expression 
gave further evidence on X chromosome status in different pattern iPSCs with different state 
of XCR.  
3.2 Perspective 
The detection system of XCR during reprogramming provides a simple method for 
isolating high quality iPSCs, which will be promising materials for regenerative therapy 
research. My data suggest that this system also provides a powerful tool for tracing the 
reprogramming and will help to clarify how XCR participates in this process. It also will help 
to clarify how to convert/rescue primed cells to naïve cells. Clarification of reprogramming 
process, including conversion from primed to naïve state, will help in the effective 
establishment of naïve human iPSCs from primed ESCs. Although my initial results have just 
pointed out the time point of reactivation, this finding enables scientists move closer steps to 
understand molecular mechanism that underlies reprogramming. Moreover, establishment of 
cell lines which are generated by using new technique CRISPR/Cas9 for the first time has 
built a new storage of cell lines which are used in XCI or XCR related experiments. 
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List of tables 
Table 1. Guide RNA sequences used in this study 
 
Sequence (5’ → 3’) 
Site in X 
chromosome 
gRNA1 CCGGGCCAGCGGGTATGCAG 
Syap1 gRNA2 GGGGGTTAGAGAGAATAGTG 
gRNA3 CCTGACGTCCACACATGGGG 
gRNA4 TTTGGTGTCTGCAGATCGAA 
Taf1 gRNA5 GTCATGGGGTCCCATTACCG 
gRNA6 CCGACTATTGGGAGCCATTA 
 
 
Table 2. Location of the intergenic regions in X chromosome used in this study  
pCAG-EGxxFP  
 
 
 
Targeting vectors 
Vector name Location (left arm) Location (right arm) 
phEF1-EGFP-IP-Syap1 
phEF1-hKO-IZ-Syap1 
162851428 - 162853765 
 (2338bp) 
162853781 - 162856225 
 (2445bp) 
phEF1-EGFP-IP-Taf1 
phEF1-hKO-IZ-Taf1 
 101625331 - 101626185 
(855bp) 
 101626196 - 101627027 
(832bp) 
 
  
Site Location (length) 
Syap1 (gRNA1, gRNA2) 162850793 - 162852499 (1707bp) 
Syap1 (gRNA3) 162853330 - 162853981 (652bp) 
Taf1 (gRNA4 ~ gRNA6) 101625420 - 101626319 (900bp) 
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Table 3. Primer sets used in genomic PCR 
Primer name Sequence (5’→3’)  
a AGGTCTCATCACGTAGCTCTGTCTTGCAACTC 
b CGCCATCACTGCCCAGCTATCTCCCAC 
c ACCTCCGCGCCCCGCAACCTCCCCTTCTAC 
d GAGTTCTGGACCGACCGGCTCGGGTTCTC 
e AGGCCCTCCGCCATCTTCTGAAGCTGAATC 
f TCTCGTTGGGGTCTTTGCTCAGGGC 
g GCCCTGAGCAAAGACCCCAACGAGA 
h GGTTTCGCCACCTCTGACTTGAGCGTC 
i AGGCCCTCCGCCATCTTCTGAAGCTGAATC 
j ATCTTCTTGGCGGCCTTGTAGGTGGTCTTGAAC 
k TGAGCGTGATCAAGCC 
l GGTTTCGCCACCTCTGACTTGAGCGTC 
m CTAGAGCAAAGAAGACTGTGGGTCAGGTCCCCTC 
n CTCCCTCCTCTGTTTCTTAATGTCAGCTCATGCAG 
o ACCTCCGCGCCCCGCAACCTCCCCTTCTAC 
p ATCTTCTTGGCGGCCTTGTAGGTGGTCTTGAAC 
q CCAAACTCATCAATGTATCTTATCATGTCTGGATCTG 
r TCTCGTTGGGGTCTTTGCTCAGGGC 
s GCCCTGAGCAAAGACCCCAACGAGA 
t GGTTTCGCCACCTCTGACTTGAGCGTC 
u TGTCCAAACTCATCAATGTATCTTATCATGTCTGG 
v ATCTTCTTGGCGGCCTTGTAGGTGGTCTTGAAC 
w TGAGCGTGATCAAGCC 
x GGTTTCGCCACCTCTGACTTGAGCGTC 
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Table 4. Primer sets used in real-time PCR 
gene name  Sequence (5’→3’) 
γ-tubulin 
Forward CGGACCTGTCGCCAGTTT 
Reverse TGCGGAACTGCTCCATGA 
Cdh1 
Forward ACGTCCCCCTTTACTGCTG 
Reverse TATCCGCGAGCTTGAGATG 
Cdh2 
Forward ATCAACCCCATCTCAGGACA 
Reverse CAATGTCAATGGGGTTCTCC 
Esrrb 
Forward TGGCAGGCAAGGATGACAGA 
Reverse TTTACATGAGGGCCGTGGGA 
Nanog 
Forward ACCTGAGCTATAAGCAGGTTAAGAC 
Reverse GTGCTGAGCCCTTCTGAATCAGAC 
Oct4 
Forward CTGTTCCCGTCACTGCTCTG 
Reverse AACCCCAAAGCTCCAGGTTC 
Rex1 
Forward TTGATGGCTGCGAGAAGAG 
Reverse ACCCAGCCTGAGGACAATC 
Tgfb1 
Forward TGAGTGGCTGTCTTTTGACG 
Reverse GGCTGATCCCGTTGATTTC 
mXist 
Forward GGTTCTCTCTCCAGAAGCTAGGAAAG 
Reverse TGGTAGATGGCATTGTGTATTATATGG 
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Table 5. Summary of established EGFP+/hKO+ clones 
Clone S site T site 
S20 S29 T36 
ESCs Express EGFP and 
hKO fluorescence. 
Express EGFP and hKO 
fluorescence. 
Express EGFP and 
hKO fluorescence. 
Monolayer 
cells 
- Express either EGFP 
or hKO fluorescence. 
 
 
 
- Suitable for XCI 
observation. 
 
- Express either EGFP 
or hKO fluorescence. 
 
 
 
- Suitable for XCI 
observation. 
- Collect hKO+ cells for 
reprogramming. 
- Express either EGFP 
or hKO fluorescence. 
- Some cells lost 
expression of both 
EGFP and hKO. 
- Maybe unsuitable for 
XCI observation. 
iPSCs (not performed 
reprogramming yet) 
Express EGFP and hKO 
fluorescence. 
(not perform 
reprogramming) 
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